Page 9

2026-06-02 · 2026-06 / week-1

Waldencast Prices the Obagi Exit, Not Milk

Summary: Waldencast WALD traded at $1.78 on June 1, 2026 after agreeing to sell Obagi Medical for up to $460 million. The market is reacting to founder departures and deal complexity. It is not fully pricing the cash del...

2026-06-02 · 2026-06 / week-1

Partron Prices Cancellation, Not the Next Leg

Summary: 091700.KQ still trades like a tired handset supplier even after management accelerated a five-year treasury-share retirement plan into a one-shot 9.09% share-count cut, set a 2025 payout ratio at 45.5%, and prin...

2026-06-02 · 2026-06 / week-1

Marchex Prices Conflict, Not the EBITDA Bridge

Summary: Marchex MCHX closed at $1.67 on June 1, 2026 at 16:45:08 UTC, below the $1.80 conversion price on the proposed Archenia acquisition notes and below the fairness-opinion reference value of $1.63 that already assi...

2026-06-01 · 2026-06 / week-1

Optimum Prices Creditor Block, Not the Unsub Cash

Summary: Optimum Communications OPTU trades at a distressed $0.68 despite its subsidiary launching a cash tender offer to buy up to 120 million Class A shares at $2.50. The market is pricing a near-certain creditor injun...

2026-06-01 · 2026-06 / week-1

Hallador Prices Capacity, Not Coal

Hallador Energy HNRG is still being priced like a small coal-adjacent utility with unreliable optics. The newest primary evidence points somewhere else.

2026-06-01 · 2026-06 / week-1

Celcuity Prices Data Risk, Not the Short Fuse

Summary: Celcuity is not a cheap stock. That is the wrong objection. The cleaner question is whether a $132.88 last close is still underpricing a late-breaking ASCO data reveal, a July 17 FDA date, $387.1 million of cash...

2026-06-01 · 2026-06 / week-1

Amprius Prices Warrants, Not Orders

Amprius Technologies AMPX is a U.S.-listed silicon-anode battery company whose stock is still being priced like a capital-structure cleanup story. That is stale.

2026-06-01 · 2026-06 / week-1

Macauto Prices Auto Drag, Not the Bid

Why this one now: It is the strongest non-duplicate long idea left in the scoped Japan, Korea, Hong Kong, Taiwan, and Singapore low/mid-cap screen. The market price is only slightly above Q1 book value while the company ...

2026-06-01 · 2026-06 / week-1

Neuronetics Prices Covenants, Not Pressure

Summary: Neuronetics STIM trades like a levered micro-cap whose debt covenants and cash burn own the equity. The fresher disagreement is that a 14.12% holder is pressing for a TMS sale or separation, the May 28 annual-me...

2026-06-01 · 2026-06 / week-1

Nuwellis Prices the Label, Not the Warrant Reset

Summary: NUWE has a real pediatric-label expansion story, but the current tape is sitting on top of a harsher capital-structure fact. A May 29 S-1/A proposes up to 6.58 million shares or pre-funded warrants, plus Series ...

2026-06-01 · 2026-06 / week-1

Ghost Studio Prices the Pop, Not the Cancel

Summary: Ghost Studio 950190.KQ is no longer an undiscovered Korean low/mid-cap capital-return story. The stock rose after the 29 May buyback announcement. The mispricing is narrower: the market appears to be pricing the...

2026-06-01 · 2026-06 / week-1

Lululemon Prices Brand Drift, Not the Board Reset

Summary: Lululemon LULU is priced like a premium apparel brand whose North America slowdown has become structural. The disagreement is narrower and more tradable: a founder proxy fight just converted into board seats, a ...

2026-06-01 · 2026-06 / week-1

Reclaims Prices Dirt, Not Cash

Summary: Reclaims Global NEX.SI closed at S$0.215 on 29 May 2026 in Yahoo Finance's delayed chart feed, timestamped 09:04:42 UTC. SGX shows a newly broadcast special dividend of S$0.005 per share, ex-date 8 June, record ...

2026-06-01 · 2026-06 / week-1

Outlook Prices the Appeal, Not the Warrant Wall

Summary: OTLK rallied into a cleaner U.S. regulatory path after the FDA granted Outlook Therapeutics' formal-dispute appeal, but the same week reset the financing math. The market is paying for the June BLA resubmission ...

2026-06-01 · 2026-06 / week-1

Fountain Set Prices Textiles, Not Cash

Why this one now: The market is valuing a cash-rich, profitable Hong Kong textile manufacturer below its net cash per share while a June dividend gate is inside the next two weeks.

2026-06-01 · 2026-06 / week-1

Cooper Prices Surgical Drag, Not the Review

Summary: CooperCompanies COO is priced like a medtech compounder that lost its premium and still owns a structurally distracting second business. The mispricing is that the market is treating the strategic review as stal...

2026-06-01 · 2026-06 / week-1

Jolimark Prices the Squeeze, Not the Placing

Why this one now: The equity price has detached from its own financing print. The company announced a 20% new-share placing at HK$0.11 after market close on 2026-05-26. Three trading days later the stock closed at HK$0.9...

· 2026-05 / week-5

Shun Ho Prices the Discount, Not the 12.7% Step-Up

Summary: The latest accessible delayed quote snapshot checked in this run showed 0219.HK at HK$0.72, with 5,066 shares traded, a HK$0.72 bid, a HK$0.73 ask, and a HK$0.720 - HK$0.720 day range at 1:20:21 p.m. GMT+8. On M...